American Capital Management’s Celgene Corp CELG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q1
Sell
-44,490
Closed -$5.15M 91
2016
Q4
$5.15M Sell
44,490
-5,320
-11% -$592K 0.4% 50
2016
Q3
$5.21M Buy
+49,810
New +$5.39M 0.4% 51
2016
Q2
Sell
-57,629
Closed -$5.77M 176
2016
Q1
$5.77M Buy
57,629
+690
+1% +$71K 0.5% 48
2015
Q4
$6.82M Buy
+56,939
New +$6.59M 0.61% 46

Other funds holding CELG

American Capital Management's CELG Position: Q1 2017 in Review

American Capital Management sold out of Celgene Corp (CELG) in Q1 2017, closing a stake of 44,490 shares — an estimated $5.15M sold.

American Capital Management first reported a position in CELG in Q4 2015 and held it in 4 quarters. The position peaked at $6.82M in Q4 2015. 1,417 funds tracked by Wall St. Rank hold CELG as of Q1 2017.

  • American Capital Management reported no remaining Celgene Corp position as of Q1 2017 after selling out during the quarter.
  • American Capital Management sold 44,490 Celgene Corp shares in Q1 2017, an estimated $5.15M.
  • American Capital Management first reported a position in Celgene Corp in Q4 2015 and held it in 4 quarters.
  • American Capital Management's Celgene Corp position peaked at $6.82M in Q4 2015.
  • 1,417 funds tracked by Wall St. Rank held Celgene Corp as of Q1 2017.

Based on American Capital Management's 13F filing for Q1 2017, filed 24 Apr 2017.